When treating a specific tendon, ligament, or muscle injury, injecting BPC-157 near the injury site concentrates the peptide where it is needed most
Phase 1 (Weeks 1 to 2): 0.25 mg subcutaneous injection once daily, morning on empty stomach Phase 2 (Weeks 3 to 6): Maintain 0.25 mg or increase to 0.5 mg based on response and tolerance Phase 3 (Weeks 7 to 8): Continue or begin taper depending on symptom improvement Maintenance: Consider cycling 4 weeks on, 2 weeks off for long-term management Oral dosing requires higher amounts to compensate for bioavailability differences
Several factors affect how often B12 injections are needed: The severity of the initial deficiency The presence of neurological symptoms Underlying health conditions affecting B12 absorption The patients response to initial therapy Ongoing monitoring of serum B12 levels By customizing the injection frequency for each patient, we make B12 therapy more effective
Anti-Inflammatory Modulation Inflammation plays a necessary role in early healing but becomes counterproductive when it persists
Moreover, vitamin B12 is a key player in the formation of red blood cells, ensuring effective oxygen transport throughout the body